Metropolis (India) eyes 60% stake in London path lab chain
Mumbai-based Metropolis Health Services is in advanced talks to acquire a 60% stake in a London-based path lab chain.
Pharma
Indian Pharmacists to start retail biz to keep MNCs away
Druggists and chemists across India have decided to get their fragmented retail business more organised in order to check the incresing presence of MNCs in the domestic market.
Lilly’s CEO Calls for Reform of US Drug Safety System
Sidney Taurel, CEO, Eli Lilly and Company called on the health care industry, medical community and U.S. government to work on a health information technology system to provide rapid and useful insights on the effectiveness of medicines while improving drug safety.
Veeda to adopt cancer hospitals for easy access to patient pool
A clinical research firm Veeda Clinical Research Pvt. Ltd is proposing a project, wherein it will adopt about a dozen cancer hospitals in tier-II and tier-III cities across India to ensure easy access to a wider patient pool for its drug test projects.
Zydus Cadila to focus on SAARC countries
After recently acquiring 100 per cent stake in the animal healthcare joint venture (JV) company
First ‘pharmacovigilance’ center launched in India
Accenture and the Bristol-Myers Squibb Company have together launched the pharmaceutical industry’s first ‘pharmacovigilance’ center, in Chennai, India, to monitor safety of data collected on medicines.
It is a different ball game in the case of patents’ filing in India
It has come to the notice that despite the presence of a patent law that guards against giving exclusive commercial rights for modifications of existing medicines, research firms, both multinational and domestic, have tried their luck on 80 patent applications on TB drugs pending with Indian patent offices across the country.
EU urged for funding generic drug industry
The European Parliament will be demanding for funds to creation of a generic drugs industry in poor countries as the long-term solution to the developing world’s health crisis.
MSPC, India launches second phase of drug CD on AIDS, TB
The Drug Information Centre (DIC) of Maharashtra State Pharmacy Council (MSPC), India is planning to launch the second phase of its interactive CD series with drug interaction information on anti ritrovirals (ARVs), anti virals and anti-TB drugs.
Making CD 4 level test accessible to HIV/ AIDS victims in India
National AIDS Control Organisation (NACO), Clinton Foundation and Becton Dickinson (BD) India, through a public-private partnership shows the way for HIV/ AIDS victims.
Counterfeit medicines endangering lives worldwide: INCB
As per the International Narcotics Control Board (INCB) President Philip O. Emafo, unregulated sales of pharmaceutical drugs, including counterfeit medicines, are undermining national drug laws and regulatory authorities while threatening the lives of patients.
Antiretroviral drugs to fight HIV/ AIDS
The antiretroviral drugs (ARVs) are designed to do interrupt the HIV/ AIDS virus at various points.
Enabling drug discovery with technology
Computational genomics, proteomics and drug design get a boost with the Centre for Genomic Application adopting high performance computing solutions to cut down the research time and costs.
